SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
VPHM - Viropharma Inc
An SI Board Since December 1998
Posts SubjectMarks Bans Symbol
2557 72 0 VPHM
Emcee:  scaram(o)uche Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1207<i>Every time the class action envelopes arrive in the mail, I throw them nigel bates-3/22/2003
1206"I was in a hurry, and wasn't thinking reasonably. That's a pretty Lance Bredvold-3/22/2003
1205>> Do I have to let the bar-flies represent them? << Nope. It takescaram(o)uche-3/21/2003
1204"But I don't consider those who ride along with a lawsuit to be whinersJohn Metcalf-3/21/2003
1203>> Looks S.O.P. to me. << Yup, agreed. Just "balance", sscaram(o)uche-3/21/2003
1202This looks like standard attorney-approved boilerplate to me. They claim meritoJohn Metcalf-3/21/2003
1201Maybe you posted hastily, but the company may have responded any way: biz.yahooJohn Metcalf-3/21/2003
1200<i>As of January 31, 2003, we had 139 full-time employees.</i> Givescaram(o)uche-3/21/2003
1199<i>Once again, the company passes on an opportunity to issue a PR and infoscaram(o)uche-3/21/2003
1198<i>ITEM 3. LEGAL PROCEEDINGS In March and May 2002, purported classcaram(o)uche-3/21/2003
1197<i>As of January 31, 2003, we had 139 full-time employees.</i>scaram(o)uche-3/21/2003
1196<i>Wyeth In December 1999, we entered into a collaboration and licensescaram(o)uche-3/21/2003
1195Once again, the company passes on an opportunity to issue a PR and inform a broascaram(o)uche-3/21/2003
1194most recent wording........... <i>and is working with Wyeth toward advancscaram(o)uche-3/21/2003
1193Product Pipeline We are focusing our current product discovery and developmescaram(o)uche-3/21/2003
119210-K out. Just starting to get into it............. Overview of Recent Developscaram(o)uche-3/21/2003
1191Relatively fresh off press, Pollack continues to do an excellent job....... ihtscaram(o)uche-3/20/2003
1190I didn't know that HIV patients got CEMA. Anybody have any insights re. plescaram(o)uche-3/14/2003
1189J Infect 2003 Feb;46(2):138-40 SPECT Scans for Monitoring Response to Pleconariscaram(o)uche-3/14/2003
1188not yet posted at Medscape........ accp.com (Nicolau's lab has an antibiotscaram(o)uche-3/12/2003
1187Update coming re. BILN 2061. Why isn't VPHM presenting? Hard to say if it&scaram(o)uche-3/12/2003
1186Message 18689625scaram(o)uche-3/12/2003
1185I'd hate to be branded as a true believer in TA, but it is interesting how Vtom pope-3/10/2003
1184Given the depth of the pockets involved in these contractual hedge agreements, Iscaram(o)uche-3/10/2003
1183This means that they do not need the entire HCV genome, but can study replicatioBiotech Jim-3/9/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):